dynorphin A-(1-13) (Human) [3121]



dynorphin A-(1-13) (Human)


SMILES CC[C@H](C)[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
InChIKey OVVIBUHLQIYUEU-IWIISZHXSA-N
Sequence YGGFLRRIRPKLK
HELM PEPTIDE1{Y.G.G.F.L.R.R.I.R.[dP].K.L.K}$$$$

Chemical Properties

Hydrogen bond acceptors 20
Hydrogen bond donors 22
Rotatable bonds 54
Log P -4.267
Molecular weight (Da) 1603.0
Stereochemistry info partial


No bioactivity data available.

dynorphin A-(1-13) (Human)


Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0


Compound is not listed as a drug.